NEWS ARCHIVE

BERLIN-CHEMIE: 45 years of inclusion and success of people with disabilities with the Social Enterprise Department

12/1/2023

The Dates of the XXVII Edition of the International Fair Play Menarini Awards

4/14/2023

Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in

1/30/2023

Ibuprofen suspension – exemption to safeguard supply of the population

1/2/2023

Berlin becomes a transfer region for green chemistry

10/6/2022

BERLIN-CHEMIE celebrates 30 years of affiliation to the MENARINI Group

9/6/2022

1 2 3 4 Next Last

Nachrichtenarchiv

Responsibility >>

International >>

Berlin Chemie